| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/05/2023 |
4
| Drapkin Kimberlee C (Director) has filed a Form 4 on KINETA, INC./DE|
Txns:
| Granted 20,000 options to buy
@ $2.58, valued at
$51.6k
|
|
| 07/05/2023 |
3
| Drapkin Kimberlee C (Director) has filed a Form 3 on KINETA, INC./DE |
| 06/07/2023 |
4
| Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 6,315 shares
@ $1.1, valued at
$6.9k
Sold 7,781 shares
@ $1.12, valued at
$8.7k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.01, valued at
$200.5k
|
|
| 04/04/2022 |
3
| Drapkin Kimberlee C (Director) has filed a Form 3 on Acumen Pharmaceuticals, Inc. |
| 02/03/2022 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 27,500 shares
@ $0
Granted 55,000 options to buy
@ $7.56, valued at
$415.8k
|
|
| 01/11/2022 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 4,595 shares
@ $7.3, valued at
$33.5k
Sold 8,222 shares
@ $6.65, valued at
$54.7k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 16,201 shares
@ $12.03, valued at
$194.9k
Sold 10,000 shares
@ $10.03, valued at
$100.3k
Sold 3,799 shares
@ $12, valued at
$45.6k
Exercised 3,016 options to buy
@ $0.48, valued at
$1.4k
Exercised 6,775 options to buy
@ $0.74, valued at
$5k
Exercised 3,710 options to buy
@ $2.36, valued at
$8.8k
Exercised 3,799 options to buy
@ $2.36, valued at
$9k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2020 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 7,200 shares
@ $8.06, valued at
$58k
|
|
| 08/18/2020 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 984 shares
@ $4.64, valued at
$4.6k
Sold 454 shares
@ $4.86, valued at
$2.2k
Sold 744 shares
@ $4.71, valued at
$3.5k
|
|
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 2,624 shares
@ $7.78, valued at
$20.4k
|
|
| 08/16/2019 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 670 shares
@ $4.1, valued at
$2.7k
Sold 648 shares
@ $4, valued at
$2.6k
Sold 1,018 shares
@ $3.92, valued at
$4k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2018 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Exercised 12,700 options to buy
@ $2.36, valued at
$30k
|
|
| 08/15/2018 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 14,400 shares
@ $0 |
|
| 03/12/2018 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 5,267 shares
@ $25.01, valued at
$131.7k
Exercised 3,759 options to buy
@ $0.48, valued at
$1.8k
|
|
| 03/07/2018 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 4,000 shares
@ $21.21, valued at
$84.8k
Sold 1,267 shares
@ $22.07, valued at
$28k
|
|
| 02/05/2018 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 97,500 options to buy
@ $23.98, valued at
$2.3M
|
|
| 01/26/2017 |
3
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 07/01/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/19/2009 |
4
| Drapkin Kimberlee C (CFO) has filed a Form 4 on EPIX Pharmaceuticals, Inc. |